Kana Sreerag, Nachiappa Ganesh Rajesh, Surendran Deepanjali, Kulkarni Rajendra G, Bobbili Ravi Kishore, Jeby Jose Olickal
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Asian J Urol. 2021 Apr;8(2):220-226. doi: 10.1016/j.ajur.2020.01.002. Epub 2020 Jan 21.
Urinary tract infection (UTI) is a common cause of morbidity and hospitalisation in the population worldwide. Upper UTI is indolent and causes subclinical acute kidney injury (AKI) resulting in preventable cause of scarring of renal parenchyma. We explored urinary and serum levels of kidney injury molecule-1 (KIM-1), haematological parameters and quantitative urine microscopy parameters to predict kidney injury.
Neutrophil-lymphocyte ratio (NLR) is obtained by dividing absolute neutrophil count with absolute lymphocyte count. Quantitative urine sediment microscopy was performed and correlated with clinical, biochemical and haematological findings to predict AKI in patients with UTI. Quantitative ELISA was performed for serum and urine levels of KIM-1. Seventy two adult patients with UTI were enrolled, 45 of whom had AKI while 27 were in the non-AKI group.
NLR (=0.005) and renal tubular epithelial cell-granular cast score in quantitative urine microscopy (=0.008) are strong predictors of AKI in patients with UTI while rest of quantitative urine microscopy parameters and serum and urinary levels of KIM-1 molecule were not found to be useful in prediction of AKI.
NLR in haemogram is a novel and useful biomarker for predicting AKI in patients with UTI.
尿路感染(UTI)是全球人群发病和住院的常见原因。上尿路感染进展缓慢,可导致亚临床急性肾损伤(AKI),进而造成肾实质瘢痕形成这一可预防的病因。我们探究了尿和血清中肾损伤分子-1(KIM-1)水平、血液学参数及定量尿镜检参数以预测肾损伤。
中性粒细胞与淋巴细胞比值(NLR)通过绝对中性粒细胞计数除以绝对淋巴细胞计数得出。进行定量尿沉渣镜检,并将其与临床、生化和血液学检查结果相关联,以预测UTI患者的AKI。对血清和尿液中的KIM-1水平进行定量酶联免疫吸附测定(ELISA)。纳入72例成年UTI患者,其中45例发生AKI,27例为非AKI组。
NLR(=0.005)和定量尿镜检中的肾小管上皮细胞-颗粒管型评分(=0.008)是UTI患者AKI的强有力预测指标,而其余定量尿镜检参数以及血清和尿液中的KIM-1分子水平在预测AKI方面并无作用。
血常规中的NLR是预测UTI患者AKI的一种新型且有用的生物标志物。